Your SlideShare is downloading. ×
0
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Us Medipharm@Network Presentation
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Us Medipharm@Network Presentation

295

Published on

Medipharm@Network\'s presentation

Medipharm@Network\'s presentation

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
295
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. French Healthcare Payers and Medical Experts<br />In depth Interviews<br />
  • 2. We understand your business<br /><ul><li>How will the recent pharma mega-merger and the growth of biotherapeutics will affect innovations in your markets?
  • 3. What opportunities lie ahead with more treatments administered by a combination of drugs and devices?
  • 4. How are contract research organisations and contract manufacturers reshaping the industry?</li></ul>The pharmaceuticals and healthcare sector <br />is going through continuous transformation.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 5. We understand your business<br /><ul><li>Contact Medipharm@Network and gain reliable insights and advice through our consultant network in over 30 areas of medical specialization
  • 6. Our Network includes amongst others
  • 7. Payers
  • 8. KOL
  • 9. Healthcare Service Providers
  • 10. Patients Organizations and Networks.
  • 11. Healthcare Practitioners and Scientists across Biotechnology and General Pharmaceutical Practices</li></ul>Access our Network of Experts<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 12. We understand your business<br />As your strategic market intelligence and advisory partner, we can help:<br /><ul><li>Advise on market potential for new vaccines or drugs across disease and treatment areas
  • 13. Identify the market size and future growth of new indications for a given drug
  • 14. Research R&D and marketing best practices from competitors and identify how this can be replicated</li></ul>Understand, Compete and Grow in French Markets<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 15. We understand your business<br />And also we can help:<br /><ul><li>Identify, evaluate and recommend potential strengths, weaknesses, threats and opportunities specifically for French Markets
  • 16. Monitor regulatory issues affecting pharmaceutical and medical equipment companies and anticipate new opportunity areas
  • 17. Deliver specific training to negative Experts or KOL that help you take your intelligence operations to the next level</li></ul>Understand, Compete and Grow in French Markets<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 18. We provide valuable information about your markets and industry<br />Flexible, Responsive and Reliable<br /><ul><li>Tap into Medipharm@Network's French research capabilities and expertise in more than 30 areas of medical specialization and access highly-targeted and strategic market intelligence very rapidly.
  • 19. Medipharm@Network has a proven record of swiftly mobilizing its Rapid Response Research resources and delivering results within days, no matter what intelligence challenges our clients face.
  • 20. Such mission-critical assignments typically make use of our professional databases, experts network and primary research capabilities in France.</li></ul>Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 21. We provide valuable information about your markets and industry<br />In brief, we can help you rapidly:<br /><ul><li> Find answers to specific questions
  • 22. Screen market players
  • 23. Profile companies, markets and products
  • 24. List out sales leads
  • 25. Analyze your competitive landscape</li></ul>Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 26. We provide valuable information about your markets and industry<br />More than 30 areas of Medical Specialisation in our Network:<br /><ul><li>Allergology
  • 27. Anaesthesia
  • 28. Anatomicopathology
  • 29. Biology
  • 30. Cardiology
  • 31. Dermatology
  • 32. Diabetology
  • 33. Endocrinology
  • 34. ENT
  • 35. ForensicMedicine
  • 36. Gastroenterology
  • 37. Geriatrics
  • 38. Gynecology
  • 39. Haematology
  • 40. Hepatology
  • 41. InfectiousDiseases
  • 42. Neurology
  • 43. Obstetrics
  • 44. Oncology
  • 45. Ophthalmology
  • 46. OrthopedicSurgery
  • 47. Plastic Surgery
  • 48. pneumology
  • 49. Psychiatry
  • 50. Radiology
  • 51. Recovery
  • 52. Rheumatology
  • 53. Stomatology
  • 54. Urology
  • 55. Virology
  • 56. VisceralSurgery</li></ul>Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 57. We provide valuable information about your markets and industry<br />Our Market Research Services include:<br /><ul><li>Competitive Landscape Analysis
  • 58. Market Attractiveness Analysis
  • 59. Market Sizing, Market Segmentation & Market Forecasts
  • 60. Competitive Benchmarking
  • 61. Competitor Deep Dive Analysis
  • 62. End User Analysis
  • 63. M&A Screening & Evaluation
  • 64. Scenario Analysis
  • 65. Market Entry Analysis
  • 66. Business Expansion Analysis</li></ul>Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 67. We provide valuable information about your markets and industry<br />Customized to your specific needs, and supported by a Team that understands your Business<br /><ul><li>Highly skilled and experienced investigators and analysts
  • 68. Customized research approach based on individual needs
  • 69. Europe-class secondary research capability and primary research capability(1)</li></ul>(1) Together with Consumed Research<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 70. Strategic analysis<br />Medipharm@Network provides analytical insight and advisory<br />Objective:<br />Enabling you to compete more effectively <br />and<br />Grow into new opportunities<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 71. Strategic analysis<br />Understand, Compete and Grow in French Markets<br />Work with a partner that has a track record of delivering strategic, timely and valuable market insights and advice in more than 30 areas of medical specialisation.<br />Whether you are seeking :<br /><ul><li>clarity on your competitive position,
  • 72. strategic initiatives,
  • 73. new markets</li></ul>Medipharm@Network will tap into its global network of over<br />150 domain experts to tailor a team that best suits <br />your strategic analysis needs.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 74. Case study examples<br />HYPERTENSION (1)<br />Hypertension-related regulatory research<br />for a consulting company<br />Key benefits<br />Gained insight on how Health Insurance Physicians working in National Health Service regulate approval of full reimbursement (100% as ALD, i.e. Long Duration Disease), with focus on Hypertension and differences in service accounting of cardiologists.<br />Need<br />A renowned consulting company needed opinions and insights of Health Insurance Physicians on specific procedures. The timeframe was just 7 days to gather their views on the topic.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 75. Case study examples<br />HYPERTENSION (2)<br />Approach:<br />In-depth interviews with Associations and Cardiologists to gain insight into approval regulations and service accounting.<br />Methods: <br />Primary research, i.e. expert and payers interviews<br />Results:<br />Regulatory and accounting information on the Health Insurance Physicians in France delivered to the client 3 days after the request.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 76. Case study examples<br />Medical Equipment (1)<br />Defined optimal market segmentation in France<br />for a medical equipment company based in US<br />Key benefits: <br />Enabled market share increase by quantifying the size of greatest opportunity customer and channel segments<br />Need:<br />A manufacturer of medical equipment wanted to size the demand for testing products in France.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 77. Case study examples<br />Medical Equipment (2)<br />Approach:<br />Multiple-level demand sizing and segmentation approach, including validation of overall market size, segmentation of customer types, and definition of channel shares for each customer type.<br />Methods: <br />Secondary & primary research and analysis<br />Results :<br />Confirmed that the demand opportunity for testing products was promising. <br />Identified channels and customer groups that would drive the greatest sales volumes within the shortest timeframe. <br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 78. Case study examples<br />Rheumatology (1)<br />Identified rheumatoid arthritis patient profiles and attitudes <br />in nine French Region versus Paris<br />Key benefits: <br />The client gained a better understanding of rheumatoid arthritis patients<br />Need:<br />A European pharmaceutical company needed to know how to better target rheumatoid arthritis patients in France.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 79. Case study examples<br />Rheumatology (2)<br />Approach:<br />Conducted in-depth interviews with rheumatoid arthritis physicians across 9 different Regions plus Paris.<br />Methods: <br />Primary research and analysis<br />Results :<br />Analyzed patients expectations and unmet needs. <br />Ranked needs and established patient profiles.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 80. Case study examples<br />Elastic Bandages (1)<br />Researched elastic bandages costs<br />of major hospitals outside French “Assistance Publique “<br />Key benefits: <br />The client gained a better understanding of the elastic bandages costs at major hospitals outside French Assistance Publique.<br />Need:<br />A global supplier wanted to benchmark its elastic bandages prices with other players in a key market.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 81. Case study examples<br />Elastic Bandages (2)<br />Approach:<br />Conducted in-depth interviews with clinical physicians, hospital pharmacists, and hospital administrators in France.<br />Methods: <br />Primary research and analysis<br />Results :<br />Established a build-up of various costs across interviewees<br />and aggregated into total usage cost.<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />
  • 82. CONTACT US …<br />Jean-François MAZELIER<br />General Manager<br />Should you have any questions or should you need<br />any additional information, please feel free to contact us:<br />medipharmanetwork@hotmail.fr<br />Cell : +336 980 690 75<br />Medipharm@Network<br />2, Esplanade de la Gare<br />95.110 - Sannois<br />- FRANCE -<br />Siret : 493 614 812 000 29 - VAT: FR 59 493 614 812<br />Ask Medipharm@Network to take advice from <br />French Healthcare Payers or Medical Experts<br />

×